Search - tctmd.com

Displaying 1 - 20 of 112

Sort: Relevancy | Date

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

News Daily News

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

December 16, 2022

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

News Daily News

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

December 09, 2022

Shifting Acute MI Outcomes by Medicare Type: A Window Into Insurer’s Influence

News Daily News

Shifting Acute MI Outcomes by Medicare Type: A Window Into Insurer’s Influence

December 09, 2022

Query Use of Nontraditional Therapies for HF at Every Visit: AHA Statement

News Daily News

Query Use of Nontraditional Therapies for HF at Every Visit: AHA Statement

December 09, 2022

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

Sequencing HF Meds? Most Doctors Stick to Old Habits, Survey Says

News Daily News

Sequencing HF Meds? Most Doctors Stick to Old Habits, Survey Says

December 08, 2022

Sodium Restriction No Help, No Harm in HF, Meta-analysis Confirms

News Daily News

Sodium Restriction No Help, No Harm in HF, Meta-analysis Confirms

November 23, 2022

Many STEMI Patients Not Treated Within National Time Goals

News Daily News

Many STEMI Patients Not Treated Within National Time Goals

Michael O'Riordan

November 15, 2022

Heart Risks Higher With Moderna vs Pfizer/BioNTech Shot, Direct Comparison Shows

News Daily News

Heart Risks Higher With Moderna vs Pfizer/BioNTech Shot, Direct Comparison Shows

November 09, 2022

STEMI Patients With In-Hospital Cardiac Arrest Bear Outsize Mortality Burden

News Daily News

STEMI Patients With In-Hospital Cardiac Arrest Bear Outsize Mortality Burden

October 31, 2022

More Endpoints, More Problems: FDA Offers Advice for Multi-endpoint Trials

News Daily News

More Endpoints, More Problems: FDA Offers Advice for Multi-endpoint Trials

Michael O'Riordan

October 28, 2022

Early Data Suggest Plant-Based Foods Could Improve Outcomes in HF

News Daily News

Early Data Suggest Plant-Based Foods Could Improve Outcomes in HF

October 26, 2022

Study Affirms Higher CVD, Mortality Risks Among COVID-Positive Patients

News Daily News

Study Affirms Higher CVD, Mortality Risks Among COVID-Positive Patients

October 26, 2022

SCAD in Men: Canadian Study Sheds Light on Rare Condition

News Daily News

SCAD in Men: Canadian Study Sheds Light on Rare Condition

October 25, 2022

Too Few Veterans Get Intensified Lipid-Lowering Therapy After Coronary Events

News Daily News

Too Few Veterans Get Intensified Lipid-Lowering Therapy After Coronary Events

Yael L. Maxwell

October 24, 2022

US Claims Data Point to Better Survival With Impella vs IABP in High-Risk PCI

News Daily News

US Claims Data Point to Better Survival With Impella vs IABP in High-Risk PCI

October 20, 2022

STRONG-HF: Fast Optimal GDMT Cuts Deaths, Hospitalizations in Acute HF

News Daily News

STRONG-HF: Fast Optimal GDMT Cuts Deaths, Hospitalizations in Acute HF

October 17, 2022

FDA: New Fix Available for Medtronic’s Troubled HeartWare VADs

News Daily News

FDA: New Fix Available for Medtronic’s Troubled HeartWare VADs

Michael O'Riordan

October 17, 2022

COVID Drug Paxlovid Interacts With Widely Used CV Meds: Review

News Daily News

COVID Drug Paxlovid Interacts With Widely Used CV Meds: Review

October 12, 2022

COAPT Risk Score Useful in Predicting Outcomes in Functional MR

News Daily News

COAPT Risk Score Useful in Predicting Outcomes in Functional MR

Michael O'Riordan

October 05, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.